NCT02044575

Brief Summary

Despite large efforts trying to improve diagnostic and therapy of sepsis have been made over the last decade (e.g. initiation of the Surviving Sepsis Campaign, defining evidence based sepsis therapy bundles) the mortality of septic shock remains high and causes high socioeconomical burden of disease. The purpose of this pilot study is to evaluate the design and conduct of a projected full scale clinical trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 20, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 24, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

April 1, 2014

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 21, 2018

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2019

Completed
Last Updated

June 16, 2020

Status Verified

June 1, 2020

Enrollment Period

3.8 years

First QC Date

January 20, 2014

Last Update Submit

June 12, 2020

Conditions

Keywords

Clock genes, circadian regulation

Outcome Measures

Primary Outcomes (1)

  • Assessment of circadian regulation

    Circadian regulation by expression of clock genes

    These parameters are measured during intensive care unit stay, for a maximum of 3 days

Secondary Outcomes (14)

  • Time on mechanical ventilation

    They are followed up until the end of intensive care unit stay - or, for a maximum of 28 days

  • Intensive care unit length of stay

    Participants will be followed for the duration of intensive care stay, an expected average of 4 weeks

  • Hospital length of stay

    Participants will be followed for the duration of intensive care stay, an expected average of 5 weeks

  • Simplified Acute Physiology Score (SOFA II)

    They are measured until the end of intensive care unit stay - or, for a maximum of 28 days.

  • Sequential Organ Failure Assessment (SOFA)

    They are measured until the end of intensive care unit stay - or, for a maximum of 28 days.

  • +9 more secondary outcomes

Other Outcomes (2)

  • Nagalase enzyme activity

    This parameter is measured at the beginning of the investigation

  • Venous return

    This parameter is measured at the beginning of the investigation

Study Arms (1)

Critically ill patients

Intensive care unit patients with refractory septic shock

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Critically ill patients with septic shock

You may qualify if:

  • Male and female patients with age 18 years and above,
  • Patient at intensive care units (8i, 9i and 1i at Charité - University Medicine Berlin , Campus Virchow- Klinikum),
  • Septic shock (ACCP/SCCM (American College of Chest Physicians/Society of Critical Care Medicine) consensus definitions) AND Norepinephrine dosage of \>0.3 μg/kg/min for at least 2 hours

You may not qualify if:

  • Pregnant or lactating female patient,
  • Acute leucemia,
  • Severe leukocytosis (\>50,000/nl),
  • Severe thrombocytopenia (\<5,000/nl),
  • Autoimmune disease with systemic medication of ≥10 mg prednisolone equivalent or previous transplantation,
  • Patients receiving interferon therapy (last 14 days),
  • Patients with known hypersensitivity GM-CSF or known antibodies against GM-CSF, yeast-derived products or any component of the study medication,
  • Ongoing (concomitant) chemotherapy or radiotherapy for malignancy,
  • Acute pulmonary embolism or acute myocardial infarction within last 72 hours,
  • Cardiopulmonary resuscitation within last 7 days,
  • Moribund patient (life expectancy \<72 hrs.),
  • Presence of a do-not-resuscitate or do-not-intubate order,
  • Known human immunodeficiency virus (HIV) infection or chronic viral hepatitis
  • Lacking willingness to save and hand out data within the study
  • Accommodation in an institution due to an official or judicial order
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow - Klinikum, Charité- Universitätsmedizin

Berlin, 13353, Germany

Location

Related Publications (3)

  • Bellet MM, Deriu E, Liu JZ, Grimaldi B, Blaschitz C, Zeller M, Edwards RA, Sahar S, Dandekar S, Baldi P, George MD, Raffatellu M, Sassone-Corsi P. Circadian clock regulates the host response to Salmonella. Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9897-902. doi: 10.1073/pnas.1120636110. Epub 2013 May 28.

    PMID: 23716692BACKGROUND
  • Lim AS, Chang AM, Shulman JM, Raj T, Chibnik LB, Cain SW, Rothamel K, Benoist C, Myers AJ, Czeisler CA, Buchman AS, Bennett DA, Duffy JF, Saper CB, De Jager PL. A common polymorphism near PER1 and the timing of human behavioral rhythms. Ann Neurol. 2012 Sep;72(3):324-34. doi: 10.1002/ana.23636.

    PMID: 23034908BACKGROUND
  • Lachmann G, Ananthasubramaniam B, Wunsch VA, Scherfig LM, von Haefen C, Knaak C, Edel A, Ehlen L, Koller B, Goldmann A, Herzel H, Kramer A, Spies C. Circadian rhythms in septic shock patients. Ann Intensive Care. 2021 Apr 26;11(1):64. doi: 10.1186/s13613-021-00833-5.

MeSH Terms

Conditions

Shock, Septic

Condition Hierarchy (Ancestors)

SepsisInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Officials

  • Claudia Spies, MD, Prof.

    Charite University, Berlin, Germany

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Department of Anesthesiology and Intensive Care Medicine, CVK/CCM, Charité - University Medicine Berlin

Study Record Dates

First Submitted

January 20, 2014

First Posted

January 24, 2014

Study Start

April 1, 2014

Primary Completion

January 21, 2018

Study Completion

March 31, 2019

Last Updated

June 16, 2020

Record last verified: 2020-06

Locations